Non-melanoma skin cancer, i.e. basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) are the most frequent tumors and their number is still increasing worldwide [1] .
may still best be viewed as an aborted malignancy that only rarely progress into an invasive SCC as proposed by Schwartz [18] or are in most cases genetically incomplete versions of SCCs.
Abrogation of UV-damage response

A role for the p53 tumor suppressor gene
What are the genetic lesions that characterize skin carcinoma development and progression?
The most prominent and best studied aberrations in skin cancers are mutation in the p53 tumor suppressor gene. While early studies suggested as many as >90% of SCCs and >50% of BCCs being mutated in the p53 gene [19] , it is now well established that about 50% of all skin cancers show mutations and this frequency rises to 90% in skin cancers of patients with xeroderma pigmentosum, a recessive disorder associated with a defect in nucleotide excision repair that predispose to skin cancer (reviewed in [20] ). Most importantly, many p53 mutations are C to T transitions with a high frequency of CC to TT double base changes, thus being indicative of UV-radiation-induced mutations [21;22] . While in e.g. colon cancer, the second p53 allele is often lost during tumor progression [23] , it is intriguing to note that in skin carcinomas both alleles can be mutated, with each allele carrying a different and mostly UV-type specific mutation [19;24] . In addition, the mutations do not appear to be at random but show a pattern of hot spots different from that of internal malignancies [25] . Giglia-Mari and Sarasin recently proposed that from these mutational hot spots mutations in codon 177 are specific only for BCCs while mutations in codon 278, although mutated at a lower frequency also in certain internal cancers, seems to be specific for skin SCCs [20] . Furthermore, since evidence is increasing that certain mutations may not only abrogate p53 function but may represent gain of function mutations (reviewed in [26] , understanding the functional consequence of these specific p53 mutations still remains an important goal for a better understanding of the mechanisms of skin cancer development.
A role for the human papilloma virus (HPV)
Similar as by mutations, p53 function is also abrogated in human skin carcinomas by the human papillomavirus (HPV) the action of which was extensively reviewed recently by Duensing and Münger [27] . More than 100 subtypes have been identified but only a subgroup of so called high-risk mucosotropic HPV types including HPV- 16, 18, 31, 33, 35, and 58, are believed to be a causative agents in the development of cervix cancer. The E6 gene of these high risk HPV types is able to induce rapid proteasomal degradation of p53 thereby abolishing the induction of cell cycle arrest or apoptosis. As in cervix carcinomas, HPV DNA is also frequently detected in skin carcinomas. A high prevalence of HPV infection seems to be characteristic for immunocompetent (47%) and even more for immunosuppressed patients (75%). However, more than 40 different HPV types were identified [28] and the typical high risk HPV types (e.g. HPV 16 and 18) were not yet found in skin carcinomas (reviewed in [29] ). Therefore, it was suggested that mechanisms different from the activity of HPV oncoproteins in gential cancer may be involved in skin neoplastic transformation [30] .
Recently it was shown that HPV38 which was detected in about 50% of skin carcinomas but only 10% of healthy skin was able to actively support longevity/immortalization of cultured human skin keratinocytes [31] . An Australian study further demonstrated HPV-38 DNA in 43% of solar keratoses, as well as 13% and 16% of SCCs and BCCs, respectively [32] . In addition, HPV-8, thought to be involved in the rare inherited disorder of epidermodysplasia verruciformis that is characterized by the life-long occurrence of multiple flat warts and macular lesions, was expressed in the epidermis of mice (Keratin 14 promoter) and these HPV-8 transgenic mice spontaneously developed single or multiple benign skin tumors [33] .
Interestingly, HPV-16 transgenic mice (also under the K14 promoter) only developed hyperplasia associated with hyperkeratosis [34] . All these still controversial findings together with the high frequency of HPV DNA in normal skin -particularly in hair follicles -and the fact that many different and often several HPV types are found concomitantly in normal and tumor tissues makes their role in skin carcinogenesis still elusive. Furthermore, a recent report that HPV DNA was frequently detected in swap samples collected from the superficial layers of skin tumors while only little HPV DNA was found in biopsies of the same tumors [35] strongly substantiates a rather critical attitude.
A role for cell cycle inhibitors
One cell cycle inhibitor that is playing an important role in epithelial transformation is the cyclin-dependent kinase inhibitor p16
INK4 that specifically inhibits progression through G1
phase of the cell cycle by blocking the cyclin-dependent kinase 4 from phosphorylating the retinoblastoma protein [36] . The INK4a locus encodes another, structurally and functionally independent protein, p14 ARF , that is also believed to be a potent tumor suppressor (reviewed in [37] 
Contribution of the ras oncogene
Another gene that is likely to be mutated by UV radiation but is controversially discussed concerning its contribution to skin cancer development is the ras oncogene. From the three ras genes, Harvey-(Ha), Kirsten-(Ki) , and N-ras, mutations in Ha-ras predominate in the general population with mutations characteristically seen at codons 12, 13, and 61 -all localized opposing UV-sensitive CC sites. Mutation frequencies were extensively analyzed in the early 1990s and at that time it was proposed that the ras oncogene significantly contributes to skin cancer development. Now, an overall mutation frequency of 10% to 20%
is suggested for SCCs and BCCs [24;47-52] . On the other hand, a high mutation frequency and prevalence for N-ras mutations was reported for xeroderma pigmentosum patients being consistent with an even more important role of UV-induced lesions and a different mutation profile in these patients [53] .
This latter situation may be reflected by the best established and most frequently used mouse model for skin carcinogenesis, the initiation -promotion protocol. Using one treatment of the carcinogen di-methyl-benzanthracene (DMBA) followed by twice weekly application of the phorbole ester (TPA) causes a ras-dependent formation of papillomas which in part progress to SCCs (reviewed in [54] ). Although the tumors formed in this model show remarkable phenotypic similarities with human skin carcinogenesis it is still an open question in how far the molecular findings based on chemical carcinogenesis and with that on "ras-dependent" skin carcinogenesis can be extrapolated and will help to unravel the as yet still poorly understood genetic pathway involved in human UV-induced skin carcinogenesis. For this, the SKH1 hairless mouse may represent a more relevant model (for review see [55] ). With these mice reproducible and quantitative data could be established on dose, time, and wavelength of UV radiation required for SCC development [56] . A high frequency of p53 mutations were found while only 1 out 32 tumors carried a ras mutation [57] . Furthermore, the majority of the p53 mutations were located in a codon matching with a hotspot for p53 mutations in human skin carcinomas, thus largely mimicking essentials of human UV-induced skin cancer.
However, careful consideration is also required when extrapolating results from these mice to humans. Differences exist e.g. in the composition of melanin and with that in the protection against UV-radiation. Increased pheomelanin photosensitizes DNA and thus induces DNA damage. Depending on skin type, various compositions of pheomelanin and another form of melanin the eumelanin are observed while eumelanin predominates in mouse melanocytes [58] .
Contribution of the patched tumor suppressor gene
While the functional contribution of the above aberrations are still far from being understood, one aberration -loss of 9q -originally detected in the autosomal dominant disorder termed
Gorlin or nevoid basal cell carcinoma syndrome (NBCC) [59] , has significantly advanced our understanding of the origin of BCCs. NBCC syndrome which is characterized by multiple [72] .
Accordingly, also mouse models demonstrated that abrogation of the ptch-sonic/hedgehog pathway (Ptch+/-mice) is essential for basal cell tumorigenesis [65] and that over-expression of Gli1, the zink-finger transcription factor activated by hedgehog, is central and probably sufficient for tumor development [66] . Interestingly, when over-expressing Gli1 under the epithelial keratin 5 (K5) promoter the mice developed predominantly follicle-derived tumors and only few BCCs [66] . However, K5-Gli2 transgenic mice exclusively developed BCCs [67] . Thus, it will be of interest to determine whether a similar distribution will be seen in human tumors.
Also in SCCs the chromosomal region 9q22 to q31 is frequently involved in aberrations.
While some tumor cells show gain of the entire q-arm due to formation of an isochromosome i(9q) ( [24] and unpublished results), LOH in 9q22.3 was reported to be characteristic for carcinomas in situ and SCCs indicating that these alterations are late events in SCC development [73] . Although it was suggested that interfollicular epidermal cells can express hair follicle markers when exposed to powerful morphogens such as SHH or WNTs [74] , there is no indication to date that patched plays a role in SCC development. Even more, while BCCs are generally associated with hyperactivation of the sonic hedgehog signaling pathway causing a continuous activation of this growth promoting cascade (reviewed in [75] ) evidence for a specific signal transduction pathway forcing SCC development is still missing.
Molecular and cytogenetic changes
So what is the difference between SCC and BCCs that no specific developmental pathway could yet be established for SCCs? Which other aberrations could account for SCC development? Already in 1994, Rees and coworkers reported on LOH of 9q in as many as 77% of BCC but only 12% of SCCs. In contrast LOH of 9p markers was frequent in SCC [41] . In addition, a number of other chromosomes were shown to carry LOH in SCCs such as 3p, 13p, 17p, and 17q [10] . Comparison with AKs and KAs revealed that AKs shared many of the same loci as SCCs while the frequency of LOH in KAs was low with only isolated losses at 9p, 9q and 10q [10;17] .
By cytogenetic analysis and comparative genomic hybridization which allows a genome wide screen of gains and losses [76] , SCCs demonstrated a great karyotypic complexity and cytogenetic heterogeneity while the aberration profile is much simpler in AKs and KAs [12;24;77;78] [24]. In SCCs Jin and colleagues found that many structural aberrations affecting centromeric regions, particularly those of chromosomes 3q, 8q, 9q, and 5p, leading to whole-arm translocations and duplication of one chromosome arm thereby causing the formation of isochromosomes [12] . They additionally observed genetically unrelated clones within the same tumor, suggesting that a multi-focal development is rather frequent in skin cancer. AKs, on the other hand, only revealed few numerical changes, e.g. gain of chromosomes 7, 9, and 18, were common while recurrent iso-chromosomes were not seen [12] . Our CGH studies suggest that gains and losses of the same chromosomes (in particular loss of 3p, 9p and gain of 11q) are involved in KAs and SCCs. The important difference, however, is that the individual KA only carries one or two of these aberrations while they are commonly present as a combination in SCCs (Popp, Jelinek, and Boukamp, unpublished) .
This further strengthens the hypothesis that, as discussed above, KAs may be genetically incomplete SCCs. Finally, multiplex fluorescence in situ hybridization (M-FISH) which identifies all chromosomes of a metaphase simultaneously [79] , highlighted complex translocations in the SCC derived cell lines [78] substantiating the important role of genomic instability in skin SCC development.
So far, the reason for the high frequency of chromosomal aberrations such as deletions, amplifications, translocations, causing the substantially deranged karyotypes of SCCs, is still elusive. Since BCCs [80] as well as Merkel cell carcinomas (MCC) [24] [81], highly aggressive endocrine tumors of the skin that develop on the same sun exposed sites, exhibit significantly less chromosomal changes per tumor, the complex karyotype of SCCs can not simply be attributed to the environment and with that to the recurrent damage by UV radiation. It also does not correlate with tumor aggressiveness, because MCCs show a much higher frequency of recurrences and metastases than SCCs [82] . However, the large spectrum of aberrations in SCCs and precursor lesions may provide a broad basis for potentially tumorigenic cells that can more rapidly adapt to environmental changes and thus may explain the high frequency of SCCs occurring in immune-suppressed patients after a relative short latency period.
Human skin cancer progression models
Different from the initiation promotion skin cancer mouse model, two human model systems have been described that show the typical SCC aberration pattern and therefore are well suited to elucidate functional consequences of the above described genetic aberrations. The MET model consists of cell lines derived from a primary tumor, two recurrences, and a metastasis from the same patient [83] . Genetic analysis of tumors and their derived cell lines provided evidence that the metastasis directly evolved from the primary tumor while the two recurrent tumors had developed independently from a precursor lesion. Furthermore, these studies demonstrated that the tumors and derived cell lines were genetically highly comparable and carried a number of aberrations typically seen in SCCs [78] . Interestingly, these cells are devoid of p53 mutations and HPV-sequences [83] thus making this sequence of human SCC cells a unique in vivo progression model to study p53-independent changes in skin carcinogenesis.
Another model, frequently used for functional studies in human skin carcinogenesis is based on the spontaneously immortalized HaCaT cells [84] . In contrast to the MET cells, the HaCaT cells exhibit UV-type specific mutations in both alleles of the p53 gene [85] . In addition, they carry chromosomal aberrations characteristically seen in SCCs [86] . Introduction of the SCCs is the increase in karyotypic complexity. This suggests that destabilizing the genome is an important driving force in skin cancer progression . Furthermore, evidence is increasing that more and more factors are contributing to genomic instability and with that provide the possibility for ever-new phenotypes including metastatic and drug-resistant ones [95] .
How can p53 contribute to the accumulation of further genetic changes?
As discussed above, mutations in the p53 gene are believed to be a very early if not initial event in skin carcinogenesis [21] . As a guardian of the genome [96] , p53 is stabilized upon stress by phosphorylation and alters the expression of different sets of downstream target genes including those which cause a cell cycle arrest [97] . Thus, damage resulting in e.g. double strand breaks, can be repaired thereby preventing gross chromosomal changes including amplifications and deletions. In p53 mutant cells cell cycle arrest is abolished. This may allow, as a first step of genome destabilization, non-lethal chromosomal damage to be passed on to the daughter cells. Such a scenario is suggested for human tumor cells that show mutations as well as MDM2 overexpression, induced aneuploidy through centrosome amplification [102] . Centrosome duplication which has to occur with each cell cycle, is thought to be controlled by the phosphorylation status of the retinoblastoma protein, release of the E2F transcription factor, and subsequent transcriptional activation of the cyclin-dependent kinase 2 (CDK2) late in G1 (reviewed in [103] ). From this it was proposed that the frequent abrogation of the Rb pathway may not only facilitate progression towards DNA replication but may also deregulate the centrosome duplication cycle [104] generating abnormal chromosome segregation and concomitantly aneuploidy.
Centrosome-mediated defects were also suggested for HPV-induced genomic instability (reviewed in [27] induce genomic instability by uncoupling centrosome duplication from cell division [107] and that E7 is responsible for abnormal centrosome synthesis [108] . In skin carcinomas mutations in the p53 gene as well as HPV DNA sequences are frequently detected. It thus remains to be seen whether one or both may be responsible for the complex aberration profile by initiating genomic instability through deregulation of the centrosome duplication cycle.
Telomere dysfunction
Recently, a strong association of chromosomal rearrangements and telomere dysfunctions was These observations long preceded the genetic definition of a telomere which, as known today, consists of thousands of repeats of the hexanucleotid TTAGGG and makes up to 15 kb in human cells. The double stranded telomeric DNA ends in a 3' single stranded overhang which is believed to be required for a higher order structure (reviewed in [110] ). One important model is that the telomeres form loop structures, the t-loops -and by invasion of the 3' overhang into the duplex region of the double stranded telomeric DNA, protect the DNA against degradation and end-to end fusion, thereby providing a protective cap for the 12 chromosomes [111] . These caps are, however, "finite" due to the failure of the DNA polymerase α to replicate linear DNA to the outermost end [112] . This so-called endreplication problem causes a replication-dependent telomere loss which in many normal somatic cells is manifested as a pattern of continuous telomere erosion and is now assumed to be the counting mechanism, the endogenous clock of cellular aging [113] . In germ line and tumor cells a specialized ribonucleoprotein complex, telomerase, is expressed that can prevent telomere shortening by de novo synthesis of telomeric sequences and thus can maintain the capping function of the telomeres [110] .
Studies with telomerase-deficient mice have shown that in late generations end-to-end chromosomal fusions were the most prominent aberrations [114] . Since they frequently involved the chromosomes with the shortest telomeres, critically short and therefore unprotected telomeres were thought to be a primary cause of these end-to-end fusions [115] .
Similarly, uncapping of the telomeres by over-expressing a dominant-negative version of the telomere repeat binding factor TRF2 further substantiated that also in human cells uncapping of the telomeres resulted in chromosomal end-to-end fusions thereby generating dicentric chromosomes [116] . If both centromeres are active, dicentric chromosomes are highly unstable during mitosis. If each centromere is attached to a different pole these chromosomes form anaphase bridges, a situation commonly viewed as a marker for genomic instability. As a result of this bipolar tension, breakage can occur anywhere along the chromosome. This led to the proposal of a fusion-bridge-breakage cycle as a primary mechanism of genomic instability in cells that suffer from critically short telomeres [117] . The highly recombinant telomere-free DNA ends may invade other chromosomes, perhaps based on areas of microhomology thereby yielding non-reciprocal translocations. This hypothesis, also known as Bridge-fusion-breakage model (BFB), is now extensively used to explain the various translocation chromosomes found in tumor cells (for review see [118] ).
Alternatively, Greider and coworkers suggest that end-to-end chromosome fusions may not initiate rearrangements but may rather be a secondary effect of end resection and thus represent stable byproducts. Studying chromosomal rearrangements in diploid yeast strains, they found that chromosomal rearrangements predominantly occur in the terminal region of the chromosome. Since exonuclease Exo1p played a major role in the generation of these rearrangements, they suggested that end resection initiates genomic instability at dysfunctional telomeres [119] .
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Trying to unravel factors responsible for impaired telomere integrity, the telomerase-deficient mice were crossed with mice deficient in a number of genes implicated in the maintenance of the telomeres such as the repair proteins Ku86, the subunit of DNA-PK, DNA-PKcs, and the poly(ADP)ribosyl polymerase PARP-1 [120;121] . While it was shown that PARP-1 had no effect in telomere metabolism and therefore did not cause obvious changes, Ku86 and DNAPKcs-deficiency caused accelerated loss of viability. This correlated with proliferative defects and age-related pathologies, but did not lead to an increased cancer incidence [122] .
This may be unexpected because late generation telomerase knock out mice were shown to suffer from an increased rate of spontaneous tumors [123] . Although it was proposed that the majority of tumor types originated from highly proliferative cell types, i.e. cells that were likely to sustain the highest degree of telomere shortening with increased age, the number of spontaneous skin carcinomas was not significantly increased. Gonzales-Suarez et al. [124] even reported on a dramatic inhibitory impact on chemical skin carcinogenesis (DMBA/TPA treatment) in the telomerase knock out mice providing evidence that short telomeres in the absence of telomerase activity could suppress tumor initiation. Along that line, absence of telomerase in transgenic mice expressing HPV16 had little effect. Genetic analyses of tumors from these nice did not provide evidence for telomere dysfunction or increased genomic instability [125] .
Constitutive over-expression of telomerase (mTERT transgenic mice), on the other hand, promoted mammary carcinomas [126] . While a skin cancer phenotype was not reported for these animals, transgenic mice over-expressing mTERT in an epithelia-specific mannerunder the K5 promoter-revealed an increased number in papillomas when subjected to the DMBA/TPA protocol suggesting an increased tumor susceptibility upon telomerase activation. Interestingly, the conversion rate to carcinomas was not augmented [127] . These mice also developed spontaneous tumors in the lung, mammary gland and uterus with lymphomas being the most frequent tumor type [128] . Stratified epithelia only showed hyperplasia and hyperkeratosis but no tumors arguing for telomerase up-regulation to be an early event in skin carcinogenesis and being related to proliferation rather than tumorigenic conversion. mTERT transgenic mice crossed into a p53 null background showed a similar tumor spectrum, though with a generally higher tumor yield [128] . Since p53 mutations are frequent in skin cancers and as discussed above represent quite a specific mutation spectrum, 14 it remains to be elucidated in how far these mutations also provide gain of function [26] and accordingly whether abrogation of p53 can replace p53 mutations in order to elucidate the mechanism of human skin cancer development and progression.
Taken together, these findings rather argue in favour of telomerase as a driving force in tumor initiation than critically shortened telomeres being the basis of unstable and therefore susceptible chromosomes. If so "telomere length-independent" mechanisms of genomic instability are required.
Putative recombination models in telomerase-positive tumor cells
While uncapping of critically short telomeres predominantly should account for normal somatic and telomerase-negative cells and therefore would represent an initial stage in the transformation process, tumor cells generally express telomerase and thus should protect their telomere lengths. Nevertheless, there is ample evidence that also these cells suffer from genomic instability and that this is not a continuum of the telomere length-dependent BFB but can occur de novo upon induction of certain oncogenes e.g. the c-myc oncogene (fore review see Mai [129] )
Genomic instability induced by the c-myc oncogene
One recurrent chromosomal aberration in SCCs is gain of chromosome 8q through the formation if an iso-chromosome. Since 8q habors the c-myc gene, located at 8q24, c-myc expression should be increased. As a result of this aberration, c-myc amplification was described for 50% of SCCs from renal transplant patients [130] . In addition to its role in proliferation, evidence is increasing that one important consequence of deregulated c-myc expression is the induction of genomic instability. c-Myc seems to favor gene amplification and gene rearrangements as well as karyotypic instability leading to numerical and structural chromosomal aberrations (for review see [129] ). The most intriguing features of c-Mycinduced alterations are their reversibility. Using inducible systems, genomic instability proved to be transient upon a single induction of c-Myc in vitro and in vivo [131] [132] . Continued cMyc activation, on the other hand, was described to be accompanied by numerical and structural chromosomal changes such as extra-chromosomal elements and chromosomal breakage but also centromere-telomere fusions. [133] . Furthermore, in the absence of p53 the c-Myc effect seemed to be augmented [134] and aberrant centrosome duplication was discussed as a potential mechanism. percentage of cells [135;136] . Since these telomeric aggregates (TAs) could be detected in interphase nuclei as well as in mitotic figures and the percentage of apoptotic cells was not significantly increased as compared to the parental cells [136] , their presence throughout the cell cycle is likely to contribute to unequal segregation of the chromosomes during mitosis,
i.e. numerical aberrations. In addition, TAs likely also force the chromosomes to alter their location, thereby providing an explanation for how different chromosomes come into such close vicinity that they are able to exchange chromosomal material and give rise to the in part very complex multi-chromosomal translocations characteristically seen in skin carcinoma cells [137] .
Telomer-independet mechanisms of chromosomal instability
Fragile sites
The Cuillo et al., provided convincing evidence that not only critically short telomeres initiate BFB. They showed that the PIP (prolactin-induced protein) gene which is over-expressed in 60 to 80% of primary and metastatic breast cancers [138] [139] was duplicated in a breast carcinoma cell line due to one cycle of BFB. In their model, the initial break was initiated at the fragile site FRA7I telomeric to the PIP gene [140] . They proposed that fusion occurs after replication of the two sister chromatids leading to anaphase bridges. Breakage now results in one deleted and one amplified daughter cell. Although the mechanism responsible for activation of fragile sites in cancer cells is not fully understood there is evidence that stress resulting from e.g. oxygen starvation (hypoxia) and subsequent variations in tumor microenvironment can activate some chromosomal fragile sites. It is also possible that fragile site expression may result from spontaneous changes in chromatin organization and/or impairment of the rate of timing of DNA replication [141] .
FRA3B, the most active common fragile site in the genome is mapped to chromosome 3p14.2, a chromosomal location frequently deleted in skin carcinomas. Furthermore, FRA3B
is encompassed by the FHIT gene (fragile histidine triad), a putative tumor suppressor that is lost in various tumors (reviewed in [142] 
DNA double strand breaks
While fragile sites favor specific sites for DNA breaks and rearrangements, DNA double strand (ds) breaks induced either in a replication-dependent manner or through exogenous insults e.g. reactive oxygen species produced by ionizing radiation or UV-A radiation are likely to occur throughout the genome and thus should cause a more random breakage.
Interestingly, Rief [144] recently found that repair of ds breaks which is dependent on nonhomologous end-joining, is also dependent on the chromatin state. They demonstrated that restriction fragment reconstitution was considerably more efficient in centromeres than in the non-centromeric locations. Since there is some experimental evidence that chromosomal exchange aberrations are less frequent in genomic regions with highly condensed heterochromatin [145] [146] [147] , this finding may support the hypothesis that the chromatin state is an important determinant of whether breaks are forced to rejoin correctly or can undergo nonhomologous end-joining with DNA from other parts of the chromosome or even other chromosomes. The authors further discuss that not only the primary structure -the high number of repetitive elements -may increase the probability for homologous repair mechanisms but that the degree of chromatin condensation may limit the mobility of the broken ends. This could additionally lead to a much higher probability of properly rejoined breaks than at an average genomic location. Thus it is tempting to speculate that the intragenomic heterogeneity of chromatin condensation may be one potential explanation for the tissue-specific prevalence of certain chromosomal alterations.
Centromeric break
The most common aberrations in skin SCCs are centromeric breaks either leading to nonreciprocal translocation of different chromosome arms or to loss of one chromosome arm and duplication of the other, resulting in the formation of an iso-chromosome. The mechanism, how these aberrations evolve is still elusive. Recently Barbouti and coworkers mapped the breakpoint region of i(17q), the most common isochromosome in human hematopoietic malignancies, and found it to be dicentric [148] . They identified large, palindromic, low-copy repeats and proposed that breakage at these palindome structures allows reunion between 17 palindromes on sister chromatids and with that the formation of both dicentric and acentric structures. While the acentric part is lost, the dicentric part is retained through mitoses without disruption. This is possible because the centromeres are in such close proximity that one of them is inactivated. The authors further concluded that such somatic rearrangements are not random events but rather reflect susceptibility due to the genomic structure [148] .
Centromeres are the primary site for kinetochore formation, the protein complex that binds to the spindle microtubules in order to coordinate chromosome segregation to the opposite poles during mitosis. A second important activity of the centromeres is the establishment and maintenance of cohesion (for review see [149] ). Therefore and as an alternative hypothesis, forced cohesion of the two sister chromatids at the centromeres could favor breakage of the less adhesive arms and maintenance of the two tightly fixed sister copies which then could reestablish as iso-chromosomes. The chromosomes involved in iso-chromosome formation seem to be tissue-specific and in skin carcinomas often involve chromosomes 3q, 8q, and 9q.
It is now essential to determine whether the genomic structure of the centromeric region of these particular chromosomes differ in keratinocytes versus other cell types and therefore are part of the non-random chromosomal changes in skin SCCs.
Conclusions and further perspective:
Comparison of the two non-melanoma skin cancers, BCC and SCC, clearly demonstrate that despite the increased knowledge about the role of a number of oncogenes, tumor suppressor genes, and signal transduction pathways, the genetic mechanisms causing tumors such as skin SCCs are still poorly understood. On the one hand, BCC exhibit a relatively simple genotype, with only few aberrations and a high degree of independence of the immune system. With the identification of an aberrant sonic hedgehog pathway, a major cause of BCC development was identified. Correspondingly, the plant-derived teratogen cyclopamine has been shown to reverse the effects of oncogenic mutations of SMO and PTCH [150] . Its efficacy in BCC treatment in humans remains to be seen and thus its application as a successful therapeutic strategy to eliminate this highly destructive and most common tumor type.
On the other hand, skin SCCs develop, at least in part, from precursor lesions and accumulate a highly complex genotype (Fig.1 ). While most of the genes causing tumor development and progression are still unknown as is a signal transduction pathway that can be causally related to SCC development, the most intriguing feature is the great number of chromosomal aberrations and the recurrent involvement of specific chromosomes in gains, losses, and translocations, e.g. loss of 3p, loss of 9p and gain of 3q, 9q, and 11q. With the increasing evidence that certain chromosomal aberrations and in particular certain combinations of aberrations are required for a fully malignant SCC, it is now of importance to unravel the mechanisms underlaying the induction of these genetic alterations. Recent studies have shown that not only UV-B but also UV-A is involved in UV-induced skin carcinogenesis (reviewed in [151] ). It now needs to be explored whether and in how far oxidative stress generated by UV-A exposure may be a factor causing such chromosomal changes, i.e. inducing genomic instability [152] . Thus, understanding and fighting genomic instability may be a promising future approach particular for those tumors such as skin SCCs that suffer from numerous and highly complex aberrations. 88. Boukamp,P., Peter,W., Pascheberg,U., Altmeier,S., Fasching,C., Stanbridge,E.J., and 
